Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clinical epidemiology of Stenotrophomonas maltophilia colonization and infection: a multicenter study.

× No keyword cloud information.

18 in total

1. Stenotrophomonas maltophilia pneumonia in cancer patients without traditional risk factors for infection, 1997-2004.

Authors: G Aisenberg; K V Rolston; B F Dickey; D P Kontoyiannis; I I Raad; A Safdar
Journal: Eur J Clin Microbiol Infect Dis Date: 2007-01 Impact factor: 3.267

2. Ecthyma Gangrenosum: A Rare Cutaneous Manifestation Caused by Stenotrophomonas maltophilia in a Leukemic Patient.

Authors: Young Min Son; So Young Na; Hye Young Lee; Jin Ok Baek; Jong Rok Lee; Joo Young Roh
Journal: Ann Dermatol Date: 2009-11-30 Impact factor: 1.444

Review 3. Antimicrobial therapy for Stenotrophomonas maltophilia infections.

Authors: A C Nicodemo; J I Garcia Paez
Journal: Eur J Clin Microbiol Infect Dis Date: 2007-04 Impact factor: 3.267

Review 4. Clinical challenges treating Stenotrophomonas maltophilia infections: an update.

Authors: Maria F Mojica; Romney Humphries; John J Lipuma; Amy J Mathers; Gauri G Rao; Samuel A Shelburne; Derrick E Fouts; David Van Duin; Robert A Bonomo
Journal: JAC Antimicrob Resist Date: 2022-05-05

5. Factors associated with mortality in patients with bloodstream infection and pneumonia due to Stenotrophomonas maltophilia.

Authors: J I Garcia Paez; F M Tengan; A A Barone; A S Levin; S F Costa
Journal: Eur J Clin Microbiol Infect Dis Date: 2008-05-16 Impact factor: 3.267

6. Stenotrophomonas maltophilia infections in a general hospital: patient characteristics, antimicrobial susceptibility, and treatment outcome.

Authors: George Samonis; Drosos E Karageorgopoulos; Sofia Maraki; Panagiotis Levis; Dimitra Dimopoulou; Nikolaos A Spernovasilis; Diamantis P Kofteridis; Matthew E Falagas
Journal: PLoS One Date: 2012-05-18 Impact factor: 3.240

7. Risk factors for mortality in patients with Stenotrophomonas maltophilia bacteremia.

Authors: Yong Duk Jeon; Woo Yong Jeong; Moo Hyun Kim; In Young Jung; Mi Young Ahn; Hea Won Ann; Jin Young Ahn; Sang Hoon Han; Jun Yong Choi; Young Goo Song; June Myung Kim; Nam Su Ku
Journal: Medicine (Baltimore) Date: 2016-08 Impact factor: 1.889

8. Treatment refractory Stenotrophomonas maltophilia bacteraemia and pneumonia in a COVID-19-positive patient.

Authors: Zachary Pek; Maria Gabriela Cabanilla; Shozab Ahmed
Journal: BMJ Case Rep Date: 2021-06-17

Review 9. Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic options.

Authors: Ya-Ting Chang; Chun-Yu Lin; Yen-Hsu Chen; Po-Ren Hsueh
Journal: Front Microbiol Date: 2015-09-02 Impact factor: 5.640

10. Emergence of Stenotrophomonas maltophilia nosocomial isolates in a Saudi children's hospital. Risk factors and clinical characteristics.

Authors: Jobran M Alqahtani
Journal: Saudi Med J Date: 2017-05 Impact factor: 1.484